Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2012
12/05/2012CN102807563A Method for preparing voriconazole and intermediate thereof
12/05/2012CN102807531A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
12/05/2012CN101565404B Heterocyclic compounds
12/05/2012CN101397294B N-substituted pyrrolidine derivates and uses thereof
12/04/2012US8324403 Carbazole derivatives; excellent hole transporting property and satisfactory electron transporting, excellent durability against electric oxidation/reduction and a high triplet excitation level; high luminous efficiency and a long lifetime
12/04/2012US8324399 Heat resistance improver and reversible thermosensitive recording medium
12/04/2012US8324385 Diacylglycerol acyltransferase inhibitors
12/04/2012US8324384 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
12/04/2012US8324380 Amino-heteroaryl-containing prokineticin 1 receptor antagonists
12/04/2012US8324265 Heterocyclic compounds having type I 11β hydroxysteroid dehydrogenase inhibitory activity
12/04/2012US8324220 Pyrimidines useful as modulators of voltage-gated ion channels
12/04/2012US8324216 Substituted piperazines
12/04/2012US8324205 Quinazoline derivatives as kinase inhibitors
12/04/2012US8323631 UV-absorbers for ophthalmic lens materials
12/04/2012US8323624 S-triazine sunscreens bearing hindered para-aminobenzalmalonate/para-aminobenzalmalonamide and aminobenzoate/aminobenzamide substituents
12/04/2012CA2695973C Novel salt of isoquinoline compound and crystal thereof
12/04/2012CA2694401C Polycyclic compound
12/04/2012CA2561313C Methods for minimizing thioamide impurities
12/04/2012CA2518932C 2,4-di(phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
11/2012
11/29/2012WO2012162482A1 Immunoconjugates, compositions containing them, and methods of making and use
11/29/2012WO2012162365A1 Substituted sulfonamides useful as antiapoptotic bcl inhibitors
11/29/2012WO2012162254A1 Inhibitors of lrrk2 kinase activity
11/29/2012WO2012161965A1 Novel imidazole derivatives useful for the treatment of arthritis
11/29/2012WO2012161205A1 Cerium complex and organic electronic element comprising cerium complex
11/29/2012WO2012161177A1 Labeled derivative for image diagnosis of tumor
11/29/2012WO2012159557A1 Substituted triazine phenylurea derivative and use thereof against tumors
11/29/2012WO2012159457A1 Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof
11/29/2012WO2012138147A3 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid crystalline form and the producing method thereof
11/29/2012WO2012136873A3 Triazine derivatives and their uses as trpv1 inhibitors
11/29/2012WO2012087976A3 Novel inhibitors of hepatitis c virus replication
11/29/2012WO2010128516A3 Process for the preparation of flibanserin involving novel intermediates
11/29/2012US20120302792 Process of making alpha-aminooxyketone/alpha-aminooxyaldehyde and alpha-hydroxyketone/alpha-hydroxyaldehyde compounds and a process making reaction products from cyclic alpha, beta-unsaturated ketone substrates and nitroso substrates
11/29/2012US20120302751 Carbazole Derivative with Heteroaromatic Ring, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Carbazole Derivative with Heteroaromatic Ring
11/29/2012US20120302597 Novel p2x7r antagonists and their use
11/29/2012US20120302576 Ampk modulators
11/29/2012US20120302541 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
11/29/2012US20120302538 Subsituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections
11/29/2012US20120302474 Oil soluble taggants
11/29/2012US20120301974 Clozapine Immunoassay
11/29/2012US20120301973 Clozapine immunoassay
11/29/2012US20120301427 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/29/2012US20120301398 Radiolabelled glutaminyl cyclase (qc) inhibitors and uses of same
11/29/2012US20120299474 Light emitting tetraphenylene derivatives, its method for preparation and light emitting device using the same derivatives
11/29/2012US20120298975 Material for organic electroluminescence devices and organic electroluminescence device using the material
11/29/2012CA2837327A1 Immunoconjugates, compositions containing them, and methods of making and use
11/29/2012CA2837199A1 Inhibitors of lrrk2 kinase activity
11/29/2012CA2836240A1 Novel imidazole derivatives useful for the treatment of arthritis
11/28/2012EP2527346A1 Photoluminescent nanoparticle, preparation, and application thereof
11/28/2012EP2527341A1 Process for preparation of pyrimidinylpyrazole compounds
11/28/2012EP2527339A1 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
11/28/2012EP2527333A1 Pyrandione, thiopyrandione and cyclohexanetrione compounds having herbicidal properties
11/28/2012EP2527330A1 Inhibitors of the hedgehog pathway
11/28/2012EP2526092A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use
11/28/2012CN102803337A New polyamide, polyimide or polyamide-imide comprising dibenzodiazocine units
11/28/2012CN102803257A Insecticidal Compounds
11/28/2012CN102803252A Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
11/28/2012CN102803251A Compound for inhibiting activity of ribonuclease, and container for storing nucleic acid containing the same
11/28/2012CN102803250A 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of CYP 17
11/28/2012CN102803249A Hepatitis c virus inhibitors
11/28/2012CN102803248A Aminoalkylpyrimidine derivatives as histamine H4 receptor antagonists
11/28/2012CN102803246A HEDGEHOG pathway antagonists and therapeutic applications thereof
11/28/2012CN102803228A Acid-labile trigger units
11/28/2012CN102803226A Cycloalkyl-substituted imidazole derivative
11/28/2012CN102803216A Heterocyclic antiviral compounds
11/28/2012CN102803210A Azetidinyl diamides as monoacylglycerol lipase inhibitors
11/28/2012CN102796084A Application of active substance to treatment of hepatitis C and preparation method thereof
11/28/2012CN102796083A Spiro heterocyclic ketone N-phenyl indole compound, its preparation method and application in controlling cardiovascular diseases and other medicine fields
11/28/2012CN102796082A Method for synthesizing ondansetron hydrochloride related substance B
11/28/2012CN102796081A Pyrimidine sulphonamide derivatives as chemokine receptor modulators
11/28/2012CN102796080A Novel azole antifungal compound and preparation method and application thereof
11/28/2012CN102796046A 2-(4-hydroxyl) phenacyl amino-acid-4, 4, 5, 5-tetramethyl-1, 3-, and preparation method and applications thereof
11/28/2012CN101497607B Process for synthesizing sunitinib
11/28/2012CN101432278B Diketo-piperazine and piperidine derivatives as antiviral agents
11/27/2012US8318928 Fused imidazole carboxamides as TRPV3 modulators
11/27/2012US8318796 Heterocyclic compounds and thrombopoietin receptor activators
11/27/2012US8318767 Substituted imidazoles as bombesin receptor subtype-3 modulators
11/27/2012US8318746 Nitrogen-containing five-membered heterocyclic compound
11/27/2012US8318735 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
11/27/2012US8318730 Fused hetrocyclic compounds
11/27/2012US8318719 Inhibitors of Bruton's tyrosine kinase
11/27/2012CA2702482C Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
11/27/2012CA2702467C Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
11/27/2012CA2680292C Intermediates useful for the preparation of n-substituted carbamoyloxyalkyl-azolium derivatives
11/27/2012CA2569592C Heterocyclic carboxamides with microbiocidal activity
11/27/2012CA2567662C Compounds and compositions as protein kinase inhibitors
11/27/2012CA2536954C C-kit modulators and methods of use
11/27/2012CA2533377C Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
11/27/2012CA2515790C Heterocyclic kinase inhibitors
11/27/2012CA2487805C Peptide deformylase inhibitors
11/27/2012CA2467374C Indole-2-carboxamides as factor xa inhibitors
11/22/2012WO2012158413A2 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
11/22/2012WO2012156334A1 Inhibitors of bruton's tyrosine kinase
11/22/2012WO2012135112A3 Methods for preparing deuterated 1,2,3-triazoles
11/22/2012US20120296098 Pentamethine Cyanine Fluorescent Dye with N-substituting at Beta-Position of Conjugated Chain
11/22/2012US20120295948 Indirubin-3'-oxime derivatives as potent cyclin dependent kinase inhibitors
11/22/2012US20120295938 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/22/2012US20120295914 Combination of adrenergic receptor agonist alpha-1 or alpha-2, preferably brimonidine with fillers, preferably hyaluronic acid
11/22/2012US20120295906 Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furane-derivatives as kinase inhibitors
11/22/2012US20120295904 Hematopoietic growth factor mimetic small molecule compounds and their uses
11/22/2012US20120295891 Novel substituted triazole derivatives as gamma secretase modulators
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 626